Seelos Therapeutics, Inc.

SEELDelisted Apr 4, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001017491

SEC filings (opens in a new tab)

Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Seelos Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of SEEL: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Of which not filed for Q3 2021	Q3 2021	Change
Holders	105	1	110	+6
Shares	40.8M	141.1K	40.8M	+114.5K (+0.3%)
Value	$107.8M	$372.0K	$98.2M	−$9.19M (−8.6%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Seelos Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to SEEL in Q3 2021
Institution	Shares	Value	% of portfolio
Norges Bank	783,800	$1.89M	0.00%
Vontobel Holding Ltd.	400,000	$964.0K	0.01%
Connor, Clark & Lunn Investment Management Ltd.	201,526	$486.0K	0.00%
Franklin Resources Inc	113,000	$272.0K	0.00%
State Board of Administration of Florida Retirement System	81,050	$195.0K	0.00%
Gsa Capital Partners LLP	80,998	$195.0K	0.02%
AdvisorShares Investments LLC	51,760	$125.0K	0.02%
Alpha Paradigm Partners, LLC	51,791	$125.0K	0.05%
Rafferty Asset Management, LLC	42,595	$103.0K	0.00%
Wells Fargo & Company	38,043	$92.0K	0.00%
Squarepoint Ops LLC	29,690	$72.0K	0.00%
Blair William & Co	28,000	$67.0K	0.00%
DLD Asset Management, LP	25,000	$60.0K	0.00%
Sovereign Financial Group, Inc.	20,000	$48.0K	0.03%
Parallax Volatility Advisers, L.P.	18,722	$45.0K	0.00%
Ameriprise Financial Inc	10,000	$24.0K	0.00%
Carmichael Hill & Associates, Inc.	2,000	$5.00K	0.00%
Total Clarity Wealth Management, Inc.	2,000	$5.00K	0.00%
Venturi Wealth Management, LLC	1,600	$4.00K	0.00%
Resolute Partners Group	1,000	$2.00K	0.00%
Ellevest, Inc.	270	$1.00K	0.00%
Quadrant Capital Group LLC	253	$1.00K	0.00%
TCI Wealth Advisors, Inc.	100	$0	0.00%
Westside Investment Management, Inc.	1,000	–	–

Sold out (18)

Institutions that held Seelos Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of SEEL in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Granite Point Capital Management, L.P.	1,350,000	$3.56M
Qube Research & Technologies Ltd	158,505	$418.0K
Old Mission Capital LLC	154,759	$409.0K
Jump Financial, LLC	152,700	$403.0K
Atom Investors LP	140,717	$371.0K
Jane Street Group, LLC	88,684	$234.0K
Walleye Capital LLC	67,063	$177.0K
Credit Suisse AG	29,244	$77.0K
Group One Trading, L.P.	28,487	$75.0K
Walleye Trading LLC	21,527	$57.0K
Bayesian Capital Management, LP	19,700	$52.0K
Price T Rowe Associates Inc	17,950	$47.0K
STRS Ohio	17,600	$46.0K
XTX Topco Ltd	11,048	$29.0K
Point72 Hong Kong Ltd	8,743	$23.0K
FMR LLC	2	$0
Cutler Group LP	100	$0
Advisory Services Network, LLC	100	$0

Not filed for Q3 2021 yet (1)

Institutions that held Seelos Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SEEL in Q2 2021 that haven't filed for Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
M Holdings Securities, Inc.	141,050	$372.0K